FHD-286
25-859
Phase 2 small_molecule active
Quick answer
FHD-286 for Small Cell Lung Cancer is a Phase 2 program (small_molecule) at Foghorn Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Foghorn Therapeutics
- Indication
- Small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active